FDA Inspection 1194141 — Daniel H. Brune, M.D.
The FDA completed an inspection of Daniel H. Brune, M.D. on Dec 15, 2022 in Peoria, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 15, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Peoria, IL (United States)
Additional Details
Clinical Investigator (CI)